Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 4Completed 2Terminated 1

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Carcinoma, Non-Small-Cell Lung 173Leukemia, Myeloid, Acute 152Breast Neoplasms 146Neoplasms 143Neoplasm Metastasis 142Colorectal Neoplasms 137Recurrence 105Ovarian Neoplasms 101Pancreatic Neoplasms 83Advanced Solid Tumor 82Lung Neoplasms 81Multiple Myeloma 77Prostatic Neoplasms 75Advanced Solid Tumors 74Stomach Neoplasms 73Squamous Cell Carcinoma of Head and Neck 72Carcinoma, Hepatocellular 68Glioblastoma 65Melanoma 64Lymphoma, Non-Hodgkin 64Triple Negative Breast Neoplasms 59Lymphoma, B-Cell 55Endometrial Neoplasms 54Myelodysplastic Syndromes 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Lymphoma 52Glioma 51Brain Neoplasms 46Carcinoma, Renal Cell 44Hematologic Neoplasms 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Recruiting × Advanced Lung Cancer × Clear all
NCT06945523 2025-06-04

Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
60 enrolled
Thoracic

Advanced Lung Cancer

NCT06992583 2025-05-28

Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
60 enrolled
Thoracic

Advanced Lung Cancer

NCT06903117 2025-04-03

Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
60 enrolled
Thoracic

Advanced Lung Cancer

NCT06768151 2025-01-10

A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

Chongqing Precision Biotech Co., Ltd

Phase 1 Recruiting
48 enrolled
Thoracic

Advanced Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡